----- Forwarded Message ----
From: HubMed - mesothelioma <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Sunday, June 22, 2008 10:52:17 PM
Subject: [Multimodal Therapy for Malignant Pleural Mesothelioma Including Extrapleural Pneumonectomy.]
[1]Zentralbl Chir. 2008 Jun; 133(3): 231-237
Sienel W, Kirschbaum A, Passlick B
Multimodal therapy including neoadjuvant chemotherapy with subsequent extrapleural pneumonectomy and postoperative radiotherapy has been shown to improve the survival of patients with malignant pleural mesothelioma (MPM) if they are selected carefully. Careful patient selection is required in order to administer aggressive multimodal therapy only to patients who will benefit from such a treatment. To achieve an accurate staging (
___
Source: http://www.hubmed.org/display.cgi?uids=18563687
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc
From: HubMed - mesothelioma <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Sunday, June 22, 2008 10:52:17 PM
Subject: [Multimodal Therapy for Malignant Pleural Mesothelioma Including Extrapleural Pneumonectomy.]
[1]Zentralbl Chir. 2008 Jun; 133(3): 231-237
Sienel W, Kirschbaum A, Passlick B
Multimodal therapy including neoadjuvant chemotherapy with subsequent extrapleural pneumonectomy and postoperative radiotherapy has been shown to improve the survival of patients with malignant pleural mesothelioma (MPM) if they are selected carefully. Careful patient selection is required in order to administer aggressive multimodal therapy only to patients who will benefit from such a treatment. To achieve an accurate staging (
___
Source: http://www.hubmed.org/display.cgi?uids=18563687
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc